Vimarsana
Biggest News Aggregation in the World

Page 21 - Jonathan Milner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathan Milner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathan Milner Today - Breaking & Trending Today

Four New Biotechs to Watch: Esker, Mogrify, Isolere and BridGene - Vimarsana News

Four New Biotechs to Watch: Esker, Mogrify, Isolere and BridGene

Published: May 05, 2021 By Mark Terry There’s money on the move and venture capital firms launch several biotech companies with hefty Series A financing rounds. Here’s a look. Esker Launches with $70 Million Series A San Francisco-based Esker Therapeutics, a Foresite Labs-incubated company, launched with a $70 million Series A financing. The round was led by Foresite Capital. The company focuses on autoimmune diseases and so-called precision therapies that target patients most likely to benefit from them. The company’s precision analytics platform is powered by Foresite Labs. ...

Mogrify Raises 17M in Second Series A Close - Vimarsana News

Mogrify Raises 17M in Second Series A Close

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Mogrify Raises $17 Million to Advance Reprogrammed Cell Therapies - Vimarsana News

Mogrify Raises $17 Million to Advance Reprogrammed Cell Therapies

Mogrify Raises $17 Million to Advance Reprogrammed Cell Therapies   Share U.K. biotech Mogrify, which is focused on novel cell-based and in vivo reprogramming for novel therapeutic applications, raised $17 million to close a series A financing round totaling $33 million. Parkwalk Advisors led the second close with additional funding from Astellas Venture Management, 24Haymarket, co-founder of Abcam, Jonathan Milner, and Mogrify CEO Darrin Disley. Mogrify aims to transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies. P...

Mogrify Completes Series A Financing Totaling $33 Million USD - Vimarsana News

Mogrify Completes Series A Financing Totaling $33 Million USD

Mogrify Completes Series A Financing Totaling $33 Million USD Second close of $17 million USD brings total raised in Series A to $33 million USD Funding led by Parkwalk Advisors with participation from strategic investor: Astellas Venture Management, as well as 24Haymarket, Dr Jonathan Milner and Dr Darrin M Disley OBE Funding will support advancement of immuno-oncology and ophthalmology programs through to IND-enabling studies, as well as continued platform development and exploration of cell reprogramming for novel therapeutic application Appointment of Dr Lorenz Mayr to the Board of Direct...

Amid housing crisis, the federal govt. banned evictions. Landlords are finding loopholes. - Vimarsana News

Amid housing crisis, the federal govt. banned evictions. Landlords are finding loopholes.

Amid housing crisis, the federal govt. banned evictions. Landlords are finding loopholes. Bracey Harris © Provided by NBC News On March 26, a sheriff’s deputy walked up to a one-story brick home in a suburb of North Tulsa, Oklahoma, and told the woman inside it was time to leave. She called Legal Aid Services of Oklahoma in a panic. Eric Hallett, the attorney on the phone, instructed her to grab important documents and medicine. There was a chance she wouldn’t be allowed to return. The woman and her partner — who lived in the home with five children, ranging in age fro...

Source: msn.com